Anplag 60mg Tablets – Ticagrelor
Original price was: ₨ 620.₨ 600Current price is: ₨ 600.
Brand Name: Anplag
Generic Name: Ticagrelor
Dosage Strength: 60mg
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 20 Tablets
Description and Usage:
Ticagrelor is typically used to prevent blood clots in patients with acute coronary syndromes, such as unstable angina or myocardial infarction (heart attack). It is often used in combination with aspirin.
Ticagrelor is a platelet aggregation inhibitor that works by blocking the P2Y12 adenosine diphosphate (ADP) receptor on platelets. This inhibition prevents platelet activation and aggregation, reducing the risk of blood clot formation.
Description
Anplag 60mg tablets, fortified with the potent antiplatelet agent Ticagrelor, emerge as a key player in cardiovascular health.
This article delves into the therapeutic advantages and the impact of Ticagrelor in promoting overall heart well-being.
Understanding Ticagrelor
Ticagrelor, the active ingredient in Anplag 60mg tablets, is a crucial antiplatelet medication known for preventing blood clot formation.
Widely prescribed for conditions such as acute coronary syndrome and post-stent placement, Ticagrelor significantly reduces the risk of recurrent cardiovascular events.
Key Benefits of Anplag 60mg Tablets
Effective Blood Clot Prevention:
Anplag 60mg tablets with Ticagrelor effectively prevent blood clot formation, reducing the likelihood of heart attacks and strokes.
Management of Acute Coronary Syndrome:
Ticagrelor’s rapid antiplatelet action in Anplag tablets effectively manages acute coronary syndrome, promoting optimal coronary blood flow.
Reduced Recurrent Cardiovascular Risk:
Anplag 60mg tablets lower the risk of recurrent cardiovascular events by inhibiting platelet aggregation, ensuring sustained heart health.
Swift Onset of Action:
Ticagrelor’s quick onset of action in Anplag tablets ensures rapid antiplatelet effects, vital in acute situations like heart attacks.
Post-Stent Placement Support:
Anplag tablets are often prescribed post-stent placement, preventing stent-related blood clots and supporting intervention success.
Well-Tolerated Formulation:
Anplag 60mg tablets offer a well-tolerated formulation, providing consistent and effective cardiovascular protection with minimal side effects.
Conclusion
Anplag 60mg tablets, enriched with Ticagrelor, stand as a reliable ally for individuals navigating cardiovascular challenges.
Whether managing acute coronary syndrome or safeguarding post-stent placement, these tablets offer a robust defense against blood clot-related complications.
Consult your healthcare professional for personalized advice on incorporating Anplag into your cardiovascular care routine.
Reviews
There are no reviews yet.